President of Cairo University Mohamed El-Khosht. Photo courtesy of Mohamed El-Khosht twiiter account
President of Cairo University Mohamed El-Khosht announced in a statement on Wednesday that the second vaccination campaign against the coronavirus in the university will start on Sunday 15 August.
The campaign, which will last for 3 weeks, will be held at the clinics of the Faculties of Law and Commerce, the statement noted.
According to El-Khosht, the campaign aims to vaccinate faculty members and employees in various university faculties and institutes who had not been vaccinated during the first campaign.
As a result of cooperation with the Ministry of Health, 3,000 doses of the Chinese Sinovac vaccine were provided for the second campaign, the statement said.
Egypt has recently started locally manufacturing the Chinese Sinovac vaccine as per an agreement between the Egyptian Holding Company for Biological Products and Vaccines (VACSERA) and the Chinese biopharmaceutical company Sinovac.
The country's plan is to produce 40 million doses by the end of 2021.
The statement added that AstraZeneca vaccines would also be available starting 26 August at the faculty of engineering’s clinic only for those who had received the first shot of the same vaccine during the first campaign, which was held in June.
At the time, Cairo University allocated 5 centres inside and outside the university campus to host the vaccination process of faculty and staff members and vaccinate them with the AstraZeneca jab.
During that first round, the university also provided the Chinese Sinopharm vaccine for the elderly and those suffering from chronic or serious diseases in cooperation with the Directorate of Health and Population in Giza, said the statement.
El-Khosht stated that the campaigns come as part of the university’s societal role and its continuous efforts to provide safety for its members, in addition to its contribution to providing free of charge coronavirus vaccines to eligible groups.
Egypt, which started its mass vaccination campaign earlier this year, has imported millions of doses of the WHO-approved British AstraZeneca vaccine, Johnson & Johnson vaccine, the Chinese Sinopharm and Sinovac vaccines. It has also acquired shipments of the Russian Sputnik V vaccine, which has not been approved by the WHO.
According to the WHO, as of 5 August, a total of 5.6 million vaccine doses have been administered in Egypt with 1.8 million fully vaccinated individuals and 3.8 million people vaccinated with at least one dose.
Egypt has reported a total number of 284,875 confirmed cases so far, including 233,405 recoveries, and 16,582 deaths.